Absci

Absci

Yahoo Finance • 2 days ago

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicin... Full story

Yahoo Finance • 21 days ago

Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?

Earlier this week, Absci Corporation reported encouraging interim Phase 1 data from its HEADLINE trial of ABS-201 for androgenetic alopecia, showing favorable safety, an estimated half-life of at least 65 days, and progression into a multi... Full story

Yahoo Finance • 23 days ago

Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble

Investing.com - U.S. stock index futures were mixed on Wednesday, with the S&P 500 and Nasdaq edging higher after a bruising two-day selloff in technology and semiconductor shares. Investors were also looking ahead to earnings from memory... Full story

Yahoo Finance • 23 days ago

Absci surges on Eli Lilly, private equity investments

[Spot lit piggy bank] PM Images * Absci (ABSI [https://seekingalpha.com/symbol/ABSI]) is up ~20% in premarket trading Monday after announcing $100M in financing from Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) as well as sever... Full story

Yahoo Finance • 23 days ago

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Absci Corporation Eli Lilly & Company, Adage, BVF Partners, Columbia Threadneedle, Invus, Redmile, and large investment management firm invest $100 million in Absci Proceeds from offering to support continued advancement of ABS-201™ acro... Full story

Yahoo Finance • 26 days ago

Is Absci Corporation (ABSI) A Good Stock To Buy Now?

Is ABSI a good stock to buy? We came across a bullish thesis on Absci Corporation on TradersPro's Substack. In this article, we will summarize the bulls' thesis on ABSI. Absci Corporation's share was trading at $7.27 as of June 15th.Ocugen... Full story

Yahoo Finance • last month

Leerink Starts Coverage on Absci Corporation (ABSI)

Absci Corporation (NASDAQ:ABSI) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 4, Leerink initiated coverage on Absci Corporation (NASDAQ:ABSI) with an Outperform rating and a $12 price target. The analyst stat... Full story

Yahoo Finance • last month

Thursday's ETF Movers: ARKG, TRFK

In trading on Thursday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 7.5% on the day. Components of that ETF showing particular strength include shares of Absci, up about 15.6% and shares of Butterfly Network, up a... Full story

Yahoo Finance • 2 months ago

The 1 AI Stock I'd Put in a Time Capsule and Open in 2036

Key Points Absci uses generative AI to design protein drugs before they are tested in a lab. Partnerships with Merck and Owkin validate Absci's hybrid AI-wet-lab drug platform. Long-term upside with this ticker depends on clinical success... Full story

Yahoo Finance • 2 months ago

Marvell Stock Climbs After AMD Reveals Surprise Stake

This article first appeared on GuruFocus. Marvell Technology (NASDAQ:MRVL) shares rose about 3% on Wednesday after Advanced Micro Devices (NASDAQ:AMD) disclosed a stake in the chipmaker in a quarterly filing, giving investors a new data p... Full story

Yahoo Finance • 2 months ago

Cathie Wood buys $12.9 million of tumbling tech stock

Cathie Wood, chief of Ark Investment Management, is known for making bold bets on fast-moving tech stocks. Sometimes her trades move just as quickly as the stocks themselves. In the week that began on May 3, Wood sold millions of dollars... Full story

Yahoo Finance • 2 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced that on May 1,... Full story

Yahoo Finance • 3 months ago

Absci Corp. (ABSI) Offering Impressive Upside to Potential Investors

Absci Corp. (NASDAQ:ABSI) is one of the 10 most shorted penny stocks to buy. As of the April 23 closing, the stock carries a strongly bullish consensus sentiment. Of the 7 analysts who provided coverage, 6 assigned Buy ratings and 1 gave... Full story

Yahoo Finance • 4 months ago

Absci Q4 2025 Earnings Preview

* Absci (ABSI [https://seekingalpha.com/symbol/ABSI]) is scheduled to announce Q4 earnings results on Tuesday, March 24th, after market close. * The consensus EPS Estimate is -$0.17 [https://seekingalpha.com/symbol/ABSI/earnings/estima... Full story

Yahoo Finance • 4 months ago

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Corporation Former Vertex executive to spearhead the clinical development of Absci’s expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue to co-chair Absci’s... Full story

Yahoo Finance • 5 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood is having a rough year as the co-founder, CEO and investment manager of Ark Invest. Her largest exchange-traded fund is trading 15% lower this year, a rough contrast to a winning year for many growth investors. She's not giving... Full story

Yahoo Finance • 7 months ago

Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial

Absci Corporation (NASDAQ:ABSI) is among the 12 Best Genomics Stocks to Invest In.Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that... Full story

Yahoo Finance • 8 months ago

SA Quant ranks Goldman's small-cap stocks with largest short interest

[Multi screen fintech investing gold and silver trading on digital screen corporating with AI artificial intelligence financial business data on commodity investment] primeimages Goldman Sachs analysts last week identified 50 small-cap st... Full story

Yahoo Finance • 8 months ago

Absci outlines dual ABS-201 proof-of-concept readouts by 2027 while prioritizing endometriosis expansion

Earnings Call Insights: Absci Corporation (ABSI) Q3 2025 MANAGEMENT VIEW * Sean McClain, Founder, CEO, President & Director, announced "interim Phase I results for ABS-101, acceleration of ABS-201 development in androgenetic alopecia (... Full story

Yahoo Finance • 9 months ago

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will be participating... Full story